<!DOCTYPE html>
<html lang="en" prefix="og: http://ogp.me/ns#">

<head>
  <link rel="stylesheet" type="text/css" href="../../assets/static/index.20a08150.css">
  <link rel="stylesheet" type="text/css" href="../../assets/static/index.7074b8c5.css">
  <link rel="stylesheet" type="text/css" href="../../assets/static/index.page.c816f47d.css">
  <link rel="stylesheet" type="text/css" href="../../assets/static/index.40f80cd8.css">
  <link rel="stylesheet" type="text/css" href="../../assets/static/index.a63779b0.css">
  <link rel="stylesheet" type="text/css" href="../../assets/static/default.page.client.e4901c18.css">
  <link rel="stylesheet" type="text/css" href="../../assets/static/default.page.server.b89a1076.css">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta http-equiv="content-type" content="text/html; charset=UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta name="HandheldFriendly" content="True">
  <meta name="MobileOptimized" content="320">
  <meta name="theme-color" content="#000000">

  <!-- Language -->
  <meta charset="UTF-8">
  <meta property="og:locale" content="en_US">



  <!-- Title -->
  <title>Series C Funding Round Announcement | Blog | Neuralink</title>
  <meta property="og:title" content="Series C Funding Round Announcement">
  <meta property="og:site_name" content="Neuralink Blog">

  <!-- Description -->
  <meta name="description"
    content="Neuralink is pleased to announce our Series C funding round of $205 million. Neuralink is developing brain-computer interfaces to treat brain related ailments.">
  <meta property="og:description"
    content="Neuralink is pleased to announce our Series C funding round of $205 million. Neuralink is developing brain-computer interfaces to treat brain related ailments.">

  <!-- Canonical URL -->
  <link rel="canonical" href="index.html">
  <meta property="og:url" content="https://neuralink.com/blog/series-c-funding-round-announcement/">

  <!-- Icon and Image -->
  <meta name="twitter:card" content="summary_large_image">
  <link rel="icon" href="../../favicon.png">
  <meta property="og:image" content="https://neuralink.com/assets/static/default.9b034b9f.png">
  <meta property="og:image:alt" content="Neuralink Logo">
  <meta property="og:image:width" content="1200">
  <meta property="og:image:height" content="630">

  <!-- Authorship -->
  <meta name="twitter:site" content="@neuralink">
  <meta name="twitter:creator" content="@neuralink">
  <meta name="author" content="Neuralink">
  <meta name="copyright" content="Copyright 2024 Neuralink">

  <!-- Miscellaneous SEO -->
  <meta name="robots" content="index,follow">
  <meta name="googlebot" content="index,follow">
  <link rel="sitemap" type="application/xml" href="../../sitemap.xml">
  <meta name="keywords"
    content="neuralink,bci,brain computer interface,clinical trial,human trial,prime study,quadriplegia,paraplegia,als">


  <meta property="og:type" content="article">

  <!-- Article Info -->
  <meta property="article:published_time" content="2021-07-29T00:00:00.000Z">
  <meta property="article:modified_time" content="2024-05-03T22:00:16.057Z">
  <meta property="article:author" content="Neuralink">


  <!-- Schema.org -->
  <script type="application/ld+json">
          {"@context":"https://schema.org","@type":"Article","url":"https://neuralink.com/blog/series-c-funding-round-announcement/","name":"Series C Funding Round Announcement | Blog | Neuralink","abstract":"Neuralink is pleased to announce our Series C funding round of $205 million. Neuralink is developing brain-computer interfaces to treat brain related ailments.","headline":"Series C Funding Round Announcement","dateCreated":"2021-07-29T00:00:00.000Z","datePublished":"2021-07-29T00:00:00.000Z","dateModified":"2024-05-03T22:00:16.057Z","image":{"@type":"ImageObject","url":"https://neuralink.com/assets/static/default.9b034b9f.png","caption":"Neuralink Logo","width":1200,"height":630},"author":[{"@type":"Organization","name":"Neuralink","logo":{"@type":"ImageObject","url":"https://neuralink.com/favicon.png","caption":"Neuralink Logo","width":96,"height":96}}]}
        </script>

  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-FR4E2J5WBJ"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag() { dataLayer.push(arguments); }
    gtag('js', new Date());

    gtag('config', 'G-FR4E2J5WBJ');
  </script>
</head>

<body>
  <div id="page-view">
    <div class="_pageHeader_c2lk8_1">
      <nav class="_nav_s9xl1_11">
        <div class="_main_s9xl1_42"><a class="_logoLink_s9xl1_26" aria-label="Neuralink Logo"
            href="../../index.html"><svg width="56" height="35" viewBox="0 0 56 35" fill="none"
              xmlns="http://www.w3.org/2000/svg" class="_logo_s9xl1_26">
              <path fill="black" fill-rule="evenodd" clip-rule="evenodd"
                d="M30.8777 22.4886H0.705078L22.5011 2.28693C24.3585 0.565492 27.0293 -0.000275522 29.47 0.809903C31.9102 1.62058 33.6439 3.6498 33.994 6.10498L37.476 30.5019C37.5803 31.2306 38.0767 31.8049 38.8036 32.0367C39.5305 32.2696 40.2868 32.0946 40.8255 31.572L50.1712 22.4886H39.4676L39.1096 20.2688H55.7051L42.4717 33.131C41.6499 33.9302 40.5593 34.3566 39.4367 34.3566C38.9823 34.3566 38.5221 34.2862 38.073 34.1429C36.5143 33.6455 35.4074 32.3656 35.1842 30.8031L31.7021 6.40672C31.4673 4.75921 30.3499 3.45166 28.7127 2.90802C27.0759 2.36337 25.3548 2.72899 24.108 3.88365L6.42923 20.2688H30.5522L30.8777 22.4886Z">
              </path>
            </svg></a>
          <div class="_buttonGroup_s9xl1_99"><a class="_underline-on-hover_s9xl1_143"
              href="../../careers/index.html">Careers</a><a class="_underline-on-hover_s9xl1_143"
              href="../index.html">Blog</a><a href="../../patient-registry/index.html" aria-disabled="false"
              class="_button_1wxcu_11 _nlkButton_s9xl1_107">Patient Registry</a>
              <a href="../employee_zone/index.php" aria-disabled="false" class="_button_1wxcu_11 _nlkButton_s9xl1_107">Exployee Login</a></div>
        </div>
        <div class="_navigationAlt_s9xl1_45 hidden"><a class="_underline-on-hover_s9xl1_143"
            href="index.html#mission">Mission</a><a class="_underline-on-hover_s9xl1_143"
            href="index.html#n1">Implant</a><a class="_underline-on-hover_s9xl1_143" href="index.html#robot">Surgical
            Robot</a><a class="_underline-on-hover_s9xl1_143" href="index.html#experience">BCI Experience</a></div>
      </nav>
    </div>
    <main id="page-blog" class="page-main">
      <article class="_main_dhhug_15">
        <header class="_blogHeader_dhhug_22">
          <div class="_publishInfo_dhhug_32"><span class="_category_dhhug_37">Announcement</span><span
              class="_circle_dhhug_43"></span><span>July 29, 2021</span></div>
          <h1>Series C Funding Round Announcement</h1>
        </header>
        <hr class="hide-on-desktop" />
        <main>
          <section class="_blogComponent_h6ibl_11 _padded_h6ibl_26 _textBlock_1sfnj_11">
            <div>
              <h4 class="_lightText_h6ibl_47">Neuralink Corp is Pleased to Announce...</h4>
              <div class="_text-md_h6ibl_63">
                <p>Our Series C funding round of $205 million, led by Vy Capital, with participation from Google
                  Ventures, DFJ Growth, Valor Equity Partners, Craft Ventures, Founders Fund, and Gigafund.</p>
                <p>We are also happy to share that a group of leading executives and entrepreneurs in areas of strategic
                  importance are also joining the round, including Robert Nelson (Co-Founder of ARCH Venture Partners),
                  Blake Byers (Byers Capital), Sam Altman (Chairman of YC Group and CEO of OpenAI), Fred Ehrsam
                  (Co-founder of Paradigm and Coinbase) and Ken Howery (Co-Founder of PayPal and Founders Fund).</p>
                <p>Neuralink has spent the last four years developing the first high channel count brain-computer
                  interface intended for therapeutic use in people with paralysis. Our first device, the N1 Link, is a
                  1024 channel device that, once implanted, would be completely invisible and able to transmit data via
                  a wireless connection. The first indication of this device would be to help people with quadriplegia
                  regain their digital freedom by potentially allowing them to interact with their computers or phones
                  in a high bandwidth and naturalistic way. The funds from the round will be used to take
                  Neuralink&rsquo;s first product to market and accelerate the research and development of future
                  devices.</p>
                <p>Neuralink was founded by Elon Musk to help those with paralysis and neurological conditions and
                  disorders in the near term and reduce AI risk to humanity in the long term. The company&rsquo;s
                  mission is to develop brain-computer interfaces that treat various brain related ailments, with the
                  eventual goal of creating a whole brain interface capable of more closely connecting biological and
                  artificial intelligence.</p>
              </div>
            </div>
          </section>
          <hr class="_bottomDivider_dhhug_80" />
        </main>
        <footer>
          <section class="_blogComponent_h6ibl_11 _padded_h6ibl_26 _container_rlxf1_1">
            <div class="_callout_rlxf1_5">
              <h3 class="_text-lg_h6ibl_70">Developing brain-computer interfaces is an interdisciplinary challenge. We
                are looking to hire a wide range of people with diverse engineering, scientific, and operations
                expertise.</h3><a tabindex="0" href="../../careers/index.html"
                class="arrowLink _link_ptmou_11 _normal_ptmou_56 _black_ptmou_80"><span
                  class="_underlined_ptmou_32">Careers</span>
                <div class="_icon_ptmou_37"><svg width="30" height="30" viewBox="0 0 30 30" fill="none"
                    xmlns="http://www.w3.org/2000/svg">
                    <path fill-rule="evenodd" clip-rule="evenodd"
                      d="M23.2198 6.07251L7.6471 6.07251L7.6471 5.07251H24.4269H24.9269V5.57251L24.9269 22.3535L23.9269 22.3535L23.9269 6.77958L5.78019 24.9276L5.07306 24.2205L23.2198 6.07251Z"
                      fill="black"></path>
                  </svg></div>
              </a>
            </div>
          </section>
        </footer>
      </article>
    </main>
    <footer class="_footer_1x8v4_11">
      <nav class="_linkCollection_1x8v4_20">
        <ol class="_linkStack_1x8v4_41">
          <li>
            <header>Company</header>
          </li>
          <li><a href="../../careers/index.html" class="">Careers</a></li>
          <li><a href="../index.html" class="">Blog</a></li>
        </ol>
        <ol class="_linkStack_1x8v4_41">
          <li>
            <header>Contact</header>
          </li>
          <li><a href="mailto:info@neuralink.com" class="">Email Now</a></li>
          <li><a href="https://x.com/neuralink" class="">X</a></li>
          <li><a href="https://www.linkedin.com/company/neuralink/" class="">LinkedIn</a></li>
          <li><a href="https://www.facebook.com/NeuralinkCorp/" class="">Facebook</a></li>
          <li><a href="https://www.instagram.com/neuralink/" class="">Instagram</a></li>
          <li><a href="https://www.youtube.com/@neuralink" class="">YouTube</a></li>
        </ol>
        <ol class="_linkStack_1x8v4_41">
          <li>
            <header>Legal</header>
          </li>
          <li><a href="../../privacy-policy/index.html" class="">Privacy Policy</a></li>
          <li><a href="../../terms-of-use/index.html" class="">Terms of Use</a></li>
        </ol><a href="../../patient-registry/index.html" aria-disabled="false"
          class="_button_1wxcu_11 _patientRegistryButton_1x8v4_54">Join Our Patient Registry</a>
      </nav>
      <div class="_patientRegistryLinkContainer_1x8v4_61"><a tabindex="0" href="../../patient-registry/index.html"
          class="arrowLink _link_ptmou_11 _sm_ptmou_62 _black_ptmou_80"><span class="_underlined_ptmou_32">Join our
            Patient Registry</span>
          <div class="_icon_ptmou_37"><svg width="30" height="30" viewBox="0 0 30 30" fill="none"
              xmlns="http://www.w3.org/2000/svg">
              <path fill-rule="evenodd" clip-rule="evenodd"
                d="M23.2198 6.07251L7.6471 6.07251L7.6471 5.07251H24.4269H24.9269V5.57251L24.9269 22.3535L23.9269 22.3535L23.9269 6.77958L5.78019 24.9276L5.07306 24.2205L23.2198 6.07251Z"
                fill="black"></path>
            </svg></div>
        </a></div>
      <div class="_bottom_1x8v4_64"><svg width="56" height="35" viewBox="0 0 56 35" fill="none"
          xmlns="http://www.w3.org/2000/svg" class="_logo_1x8v4_71">
          <path fill="black" fill-rule="evenodd" clip-rule="evenodd"
            d="M30.8777 22.4886H0.705078L22.5011 2.28693C24.3585 0.565492 27.0293 -0.000275522 29.47 0.809903C31.9102 1.62058 33.6439 3.6498 33.994 6.10498L37.476 30.5019C37.5803 31.2306 38.0767 31.8049 38.8036 32.0367C39.5305 32.2696 40.2868 32.0946 40.8255 31.572L50.1712 22.4886H39.4676L39.1096 20.2688H55.7051L42.4717 33.131C41.6499 33.9302 40.5593 34.3566 39.4367 34.3566C38.9823 34.3566 38.5221 34.2862 38.073 34.1429C36.5143 33.6455 35.4074 32.3656 35.1842 30.8031L31.7021 6.40672C31.4673 4.75921 30.3499 3.45166 28.7127 2.90802C27.0759 2.36337 25.3548 2.72899 24.108 3.88365L6.42923 20.2688H30.5522L30.8777 22.4886Z">
          </path>
        </svg><span>© Neuralink <!-- -->2024</span></div>
    </footer>
  </div>
  <script type="module" src="../../assets/entries/entry-server-routing.a9256dcd.js" defer></script>
  <link rel="modulepreload" href="../../assets/entries/pages_blog_post_index.page.67060ea2.js" as="script"
    type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-d0300abc.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-703f522e.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-5c891ec2.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-ef86a6e3.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-f3b9c0aa.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-6269211f.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-39bbbe94.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-e905571f.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-cc51208d.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-eab8fe09.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/entries/renderer_default.page.client.bfe273ea.js" as="script"
    type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-e948ec12.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-d877d5af.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-4605052d.js" as="script" type="text/javascript" crossorigin>
  <link rel="modulepreload" href="../../assets/chunks/chunk-f2620b57.js" as="script" type="text/javascript" crossorigin>
  <script id="vite-plugin-ssr_pageContext"
    type="application/json">{"pageContext":{"_pageId":"/pages/blog_post/index","pageProps":{"updatedOn":"!Date:2024-05-03T22:00:16.057Z","fields":{"title":"Series C Funding Round Announcement","release_date":"2021-07-29T00:00:00","category":"announcement","footer":"careers","read_time":3,"intro_text":"\u003cp>Neuralink Corp is pleased to announce our Series C funding round of $205 million, led by Vy Capital, with participation from Google Ventures, DFJ Growth, Valor Equity Partners, Craft Ventures, Founders Fund, and Gigafund.\u003c/p>","summary":"Neuralink is pleased to announce our Series C funding round of $205 million. Neuralink is developing brain-computer interfaces to treat brain related ailments.","components":[{"type":"text_block","fields":{"title":"Neuralink Corp is Pleased to Announce...","body":"\u003cp>Our Series C funding round of $205 million, led by Vy Capital, with participation from Google Ventures, DFJ Growth, Valor Equity Partners, Craft Ventures, Founders Fund, and Gigafund.\u003c/p>\n\u003cp>We are also happy to share that a group of leading executives and entrepreneurs in areas of strategic importance are also joining the round, including Robert Nelson (Co-Founder of ARCH Venture Partners), Blake Byers (Byers Capital), Sam Altman (Chairman of YC Group and CEO of OpenAI), Fred Ehrsam (Co-founder of Paradigm and Coinbase) and Ken Howery (Co-Founder of PayPal and Founders Fund).\u003c/p>\n\u003cp>Neuralink has spent the last four years developing the first high channel count brain-computer interface intended for therapeutic use in people with paralysis. Our first device, the N1 Link, is a 1024 channel device that, once implanted, would be completely invisible and able to transmit data via a wireless connection. The first indication of this device would be to help people with quadriplegia regain their digital freedom by potentially allowing them to interact with their computers or phones in a high bandwidth and naturalistic way. The funds from the round will be used to take Neuralink&rsquo;s first product to market and accelerate the research and development of future devices.\u003c/p>\n\u003cp>Neuralink was founded by Elon Musk to help those with paralysis and neurological conditions and disorders in the near term and reduce AI risk to humanity in the long term. The company&rsquo;s mission is to develop brain-computer interfaces that treat various brain related ailments, with the eventual goal of creating a whole brain interface capable of more closely connecting biological and artificial intelligence.\u003c/p>","left_block":""}}],"preview_image":{"image":"","width":"","height":"","image_alt":""}},"isDraft":false},"urlPathname":"/blog/series-c-funding-round-announcement"}}</script>
</body>

</html>